Healthcare CRM Research
6 comprehensive market analysis studies and research reports on the Healthcare CRM sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 90 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
6 Healthcare Reports
Categories
Filters and Sort
Showing 6 of 6 results in Healthcare CRM
Global Healthcare Interoperability Solutions Market
CAGR: 11.31%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Koninklijke Philips, Epic Systems, NextGen Healthcare, Oracle, Koch Software Investments
Hospital Asset Tracking And Inventory Management Systems Market
CAGR: 5.5%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:GE Healthcare, Stanley Healthcare, Zebra Technologies, CenTrak, Honeywell International
Medication Adherence Market
CAGR: 14.04%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:AdhereTech, Mckesson, Omnicell, Medminder, Cardinal Health
Healthcare CRM Market
CAGR: 12.58%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:IBM, Microsoft, Oracle, Salesforce Inc, SAP
Global Pharmaceutical Customer Relationship Management Software Market
CAGR: 10.5%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Kapture, Medsimo Technologies, Actis Sales Technologies, Synergistix, SoftDent
Healthcare Quality Management Market
CAGR: 14.53%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Oracle, Optum, Merative, Premier, RLDatix
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
